[1]
Demir, A.N. et al. 2025. Increasing cumulative cabergoline dose in patients with prolactinoma improves metabolic parameters independently of decrease in prolactin levels. The European Research Journal. 11, 1 (Jan. 2025), 80–87. DOI:https://doi.org/10.18621/eurj.1564695.